| Product |
Tech
Pack |
DMF |
Indian
Patent |
PCT |
Therapeutic Category |
Open
Part |
EU |
US |
CEP |
KOREA |
| Abiraterone Acetate |
|
|
|
|
|
|
|
|
|
| Azacitidine |
* |
|
|
|
|
|
|
|
Anti Neoplastic Agent |
| Bendamustine Hydrochloride |
 |
|
|
* |
|
|
|
|
| Bexarotene |
* |
|
|
|
|
|
|
|
| Bicalutamide |
|
|
|
* |
|
|
|
|
| Bortezomib |
|
|
|
* |
|
|
|
|
| Cabazitaxel* |
|
|
|
|
|
|
|
|
| Capecitabine |
|
|
|
* |
|
|
|
|
| Crizotinib |
|
|
|
|
|
|
|
|
| Dasatinib |
* |
|
|
|
|
|
|
|
| Decitabine |
* |
|
|
|
|
|
|
|
| Docetaxel |
|
|
|
* |
|
|
|
|
| Erlotinib Hydrochloride |
|
|
|
* |
|
|
|
|
| Gemcitabine Hydrochloride |
|
|
|
* |
|
|
|
|
| Imatinib Mesylate |
|
|
|
* |
|
|
|
|
| Irinotecan |
|
|
|
|
|
|
|
|
| Ixabepilone |
* |
|
|
|
|
|
|
|
| Lapatinib |
* |
|
|
|
|
|
|
|
| Nilotinib* |
|
|
|
|
|
|
|
|
| Paclitaxel |
|
|
|
|
|
|
|
|
| Pazopanib Hydrochloride |
* |
|
|
* |
|
|
|
|
| Pemetrexed |
|
|
|
|
|
|
|
|
| Sorafenib Tosylate |
* |
|
|
|
|
|
|
|
| Topotecan |
|
|
|
|
|
|
|
|
| Vemurafenib |
|
|
|
|
|
|
|
|
|
| PROSTAGLANDINS |
| Alprostadil* |
|
|
|
|
|
|
|
|
Erectile Dysfunction |
| Bimatoprost |
* |
|
|
* |
|
|
|
|
Glaucoma & Ocular
Hypertension |
| Carboprost Tromethamine |
* |
|
|
|
|
|
|
|
Induces Contractions |
| Epoprostenol Sodium |
|
|
|
* |
|
|
|
|
Pulmonary Hypertension |
| Iloprost |
* |
|
|
|
|
|
|
|
Anti hypertensive |
| Latanoprost |
* |
|
|
* |
|
|
|
|
Glaucoma & Ocular
Hypertension |
| Misoprostol* |
|
|
|
|
|
|
|
|
Induces Labour |
| Travoprost* |
* |
|
|
|
|
|
|
|
Glaucoma & Ocular
Hypertension |
| Treprostinil Sodium* |
|
|
|
|
|
|
|
|
PAH |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| * * - Filed |
|
|
|
|
|
|
|
|
|
| * - Under Development |
|
|
|
|
|
|
|
|
| Note: Above products will NOT be supplied to countries in which these could be in conflict with existing patents. The final responsibility lies exclusively with the buyer. |
|
|
|
|
